Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics, 1st Edition
Author :
Edited by Giuseppe Limongelli, MD, PhD, Michele Emdin, MD, Marco Merlo, MD and Emanuele Monda
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects
...view more
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.
Key Features
Contains 17 relevant, practice-oriented topics including the changing epidemiology of cardiac amyloidosis; arrhythmic stratification of cardiac amyloidosis: state of the art; specific therapy in ATTR-related cardiomyopathy: future perspectives beyond tafamidis; and more.
Provides in-depth clinical reviews on amyloid cardiomyopathies, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Giuseppe Limongelli, MD, PhD, University of Campania “Luigi Vanvitelli Monaldi Hospital,; Michele Emdin, MD, Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana; Marco Merlo, MD, Institute of Life Sciences, Scuola Superiore , Sant’Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana, and Emanuele Monda, Department of Translational Medical Sciences, University of Campania, Naples, Italy
Edited by Giuseppe Limongelli, MD, PhD, University of Campania “Luigi Vanvitelli Monaldi Hospital,; Michele Emdin, MD, Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana; Marco Merlo, MD, Institute of Life Sciences, Scuola Superiore , Sant’Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana, and Emanuele Monda, Department of Translational Medical Sciences, University of Campania, Naples, Italy
Amyloidosis and Amyloidogenesis: One Name, Many Diseases Pathophysiology of Cardiac Amyloidosis The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis Clinical Use of Biomarkers in Cardiac Amyloidosis Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update Standard Therapy in Cardiac Amyloidosis: What is Known, What is “Gray” Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis
https://www.asia.elsevierhealth.com/amiloid-cardiomyopathies-clinical-diagnostic-and-therapeutic-aspects-an-issue-of-heart-failure-clinics-9780443121432.html312403Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780443121432_7.jpg66.7488.99USDInStock/Medicine/Cardiology/Medicine/Cardiology/Clinics/Clinics/Japan Titles/Medicine & Surgery/Cardiology/Clinics50545695259850505466652550415263160443121243887251488653650545535145120525983341826924335088In this issue of <i>Heart Failure Clinics</i>, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of <b>Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects</b>. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more. In this issue of <i>Heart Failure Clinics</i>, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of <b>Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects</b>. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.00add-to-cart97804431214322024ProfessionalEdited by Giuseppe Limongelli, MD, PhD, Michele Emdin, MD, Marco Merlo, MD and Emanuele Monda20241Book178w x 254h (7.00" x 10.00")Elsevier240Jun 13, 2024IN STOCKEdited by <STRONG>Giuseppe Limongelli</STRONG>, MD, PhD, University of Campania “Luigi Vanvitelli Monaldi Hospital,; <STRONG>Michele Emdin</STRONG>, MD, Institute of Life Sciences, Scuola Superiore Sant’Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana; <STRONG>Marco Merlo</STRONG>, MD, Institute of Life Sciences, Scuola Superiore , Sant’Anna, Pisa, Italy, Fondazione Toscana G. Monasterio, CNR-Regione ,Toscana, and <STRONG>Emanuele Monda</STRONG>, Department of Translational Medical Sciences, University of Campania, Naples, ItalyClinicsClinicsThe Clinics: Internal MedicineUnited StatesYesYesNoNoPlease SelectPlease SelectPlease Select
